Clinical Trials Directory

Trials / Completed

CompletedNCT02346331

Epidemiology, Acute Management, and Outcomes of Patients With Sepsis Presenting to a Referral Hospital in Western Kenya

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
198 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sepsis is a clinical syndrome representing deranged hemodynamics (such as tachycardia) secondary to severe infection. In high-income countries (HICs), early resuscitation of septic patients with protocol-driven therapy, including quantitative fluid administration guided by invasive monitoring, has resulted in improved outcomes for septic patients. Prevalence and mortality of sepsis are thought to be higher in sub-Saharan Africa (SSA) than in high-income countries; however, most hospitals in SSA lack the technology and resources necessary to implement the resuscitation protocols used in HICs and therefore, mortality from sepsis remains high. The World Health Organization (WHO) has recently disseminated an algorithm for resuscitation of septic patients in low resource settings. This algorithm is based on expert consensus only, and its efficacy has never been tested. This study will be conducted in the Casualty Department of Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya. The purpose of this study is to describe the epidemiology of patients presenting with severe sepsis, to examine the microbiology causing severe sepsis, to describe current management and outcomes for severe sepsis, and to test the effect of implementation of the WHO resuscitation algorithm at MTRH. The study design is a prospective before and after clinical trial. In an initial observational phase, adult patients presenting to the MTRH Casualty Department with sepsis and severe sepsis (the latter of which will be defined by elevated lactate) will be enrolled into a prospective observational cohort. Demographic data, medical characteristics, and microbiological studies will be obtained, then the management and outcomes of these patients will be observed. In a second phase, patients with sepsis will continue to be enrolled into a prospective observational cohort, while patients with severe sepsis will be enrolled into an intervention group. Patients in the intervention group will be managed according to the WHO resuscitation algorithm. Specifically, the WHO algorithm involves fluid boluses guided by vital signs and physical exam findings, rapid and early administration of empiric antibiotics, and frequent patient monitoring. The outcomes of interest are achievement of lactate clearance, which is a correlate of tissue perfusion, as well as 24-hour, in-hospital, and 30-day mortality.

Conditions

Interventions

TypeNameDescription
OTHERWHO algorithm of fluid boluses guided by physical examination
OTHERFrequent patient monitoringVital signs and physical exam every 30-60 minutes
OTHEREarly administration of empiric antibioticsClinician will be prompted to administer antibiotics within 60 minutes
OTHEROxygen delivery
OTHERCorrection of hypoglycemiaIf blood glucose is less than 3.0 mmol/L, IV dextrose will be administered
OTHERCorrection of severe anemiaIf hemoglobin is less than 7 mg/dL, clinician will be prompted to offer blood transfusion

Timeline

Start date
2015-01-01
Primary completion
2016-08-01
Completion
2016-09-01
First posted
2015-01-27
Last updated
2018-01-05

Locations

1 site across 1 country: Kenya

Source: ClinicalTrials.gov record NCT02346331. Inclusion in this directory is not an endorsement.